Uterine Fibroids Treatment in India for International Women Patients (2026)
Uterine fibroids are non-cancerous growths that develop in or on the muscular wall of the uterus. They are among the most common gynaecological conditions worldwide, affecting up to 80% of women by the age of 50. Women of African descent face a disproportionately higher burden — fibroids tend to appear earlier, grow larger, and produce more severe symptoms in this population. For many women in sub-Saharan Africa, access to advanced fibroid treatment remains limited, making India an increasingly sought-after destination for affordable, high-quality gynaecological care.
TL;DR: India offers the full spectrum of fibroid treatments — medication, uterine artery embolisation, laparoscopic/robotic myomectomy, open myomectomy, hysterectomy, and MRI-guided focused ultrasound — at 70–85% lower cost than the USA. Myomectomy costs USD 2,000–5,000 in India versus USD 15,000–25,000 in the USA. Fertility-preserving options are available at all major centres.
Understanding Uterine Fibroids
Fibroids (also called leiomyomas or myomas) vary widely in size, number, and location. A woman may have a single small fibroid causing no symptoms or multiple large fibroids causing significant problems. The location within the uterus determines the type: subserosal fibroids grow on the outer surface, intramural fibroids develop within the muscular wall, and submucosal fibroids project into the uterine cavity.
Common symptoms include:
- Heavy or prolonged menstrual bleeding
- Pelvic pain or pressure
- Frequent urination due to bladder pressure
- Difficulty conceiving or recurrent miscarriage
- Abdominal bloating or visible enlargement
Not all fibroids require treatment. Small, asymptomatic fibroids are often monitored with regular ultrasound. Treatment is considered when fibroids cause significant symptoms, rapid growth, or fertility problems.
Treatment Options Available in India
India's gynaecological centres offer every established treatment modality for fibroids. The choice depends on fibroid characteristics, symptom severity, the patient's age, and whether she wishes to preserve fertility.
Medical Management
Hormonal medications — including GnRH agonists, oral contraceptives, and the newer GnRH antagonists — can shrink fibroids temporarily and control bleeding. These are often used as a bridge therapy before surgery or in women approaching menopause. Medical management alone does not eliminate fibroids; they typically regrow after medication is stopped.
Uterine Artery Embolisation (UAE)
UAE is a minimally invasive procedure performed by an interventional radiologist. Tiny particles are injected through a catheter into the uterine arteries, blocking blood flow to the fibroids and causing them to shrink. Hospital stay is typically 1–2 days, and recovery takes 1–2 weeks. UAE is suitable for women who want to avoid surgery but is generally not recommended for women planning future pregnancies due to uncertain effects on fertility.
Myomectomy: Preserving the Uterus and Fertility
Myomectomy removes fibroids while leaving the uterus intact. It is the preferred option for women who want to conceive in the future. India's leading gynaecological centres perform myomectomy using three approaches:
Laparoscopic myomectomy: Small incisions, camera-guided removal. Best for fewer than 4 fibroids, each under 10 cm. Hospital stay is 2–3 days with 1–2 week recovery.
Robotic myomectomy: Uses robotic arms for enhanced precision and suturing. Particularly useful for fibroids in difficult locations. Available at hospitals equipped with the da Vinci surgical system. Similar recovery profile to laparoscopic surgery.
Open myomectomy (laparotomy): A larger abdominal incision used for very large or numerous fibroids. Hospital stay is 4–5 days with 4–6 week recovery. Sometimes the only practical option when fibroids exceed 15 cm or number more than 10.
Hysteroscopic myomectomy: For submucosal fibroids projecting into the uterine cavity. Performed through the cervix with no abdominal incisions. Typically done as a day procedure with same-day or next-day discharge.
Studies show pregnancy rates of 40–60% within two years after myomectomy in women with fibroid-related infertility. Fibroid recurrence occurs in 15–30% of women within 5 years, though many recurrences do not require further surgery.
Hysterectomy
Removal of the uterus is a definitive solution for women who have completed childbearing and want permanent relief. It eliminates the possibility of fibroid recurrence. In India, hysterectomy is increasingly performed laparoscopically or robotically, reducing hospital stays to 2–3 days and recovery to 2–4 weeks. Total abdominal hysterectomy remains an option for very large uteri.
MRI-Guided Focused Ultrasound (MRgFUS)
This non-invasive technique uses focused ultrasound waves guided by MRI to heat and destroy fibroid tissue without any incisions. It is available at select centres in India and is suitable for women with a limited number of fibroids in accessible locations. Recovery is minimal — most patients return to normal activities within 1–2 days.
Cost Comparison: India vs. the USA
| Procedure | India (USD) | USA (USD) |
|---|---|---|
| Laparoscopic myomectomy | 2,000–4,000 | 15,000–22,000 |
| Robotic myomectomy | 3,000–5,000 | 18,000–25,000 |
| Open myomectomy | 2,000–3,500 | 12,000–18,000 |
| Uterine artery embolisation | 2,500–4,000 | 10,000–18,000 |
| Laparoscopic hysterectomy | 2,500–4,500 | 15,000–25,000 |
| MRI-guided focused ultrasound | 3,000–5,000 | 12,000–20,000 |
All figures include hospital charges, surgeon and anaesthesia fees, and standard post-operative care. Travel, accommodation, and companion expenses typically add USD 1,500–2,500 for a 2–3 week stay.
Choosing the Right Treatment
The decision depends on several factors that should be discussed with a gynaecologist experienced in fibroid management:
- Fertility goals: Women wanting future pregnancies should generally choose myomectomy over UAE or hysterectomy
- Fibroid size and number: Large or numerous fibroids may require open surgery
- Fibroid location: Submucosal fibroids are best addressed hysteroscopically; subserosal fibroids may respond well to UAE
- Symptom severity: Severe anaemia from heavy bleeding may require urgent intervention
- Age and proximity to menopause: Fibroids typically shrink after menopause, which may influence timing
Recovery and Returning Home
Recovery timelines vary by procedure. For laparoscopic or robotic surgery, most patients are walking within 24 hours and discharged within 2–3 days. Open myomectomy requires a longer hospital stay of 4–5 days and a more gradual return to activity.
Regardless of procedure type, surgeons in India typically require a minimum 10–14 day post-discharge stay before clearing international patients to fly. This allows time for wound check, suture removal if applicable, and confirmation that recovery is progressing normally.
After returning home, patients follow up with their local gynaecologist and may have telemedicine consultations with their Indian surgeon during the first few months. An ultrasound at 3 months and 12 months post-surgery is standard to assess healing and check for recurrence.
Starting the Process
International women patients considering fibroid treatment in India should begin by sharing their medical records — including pelvic ultrasound or MRI reports, blood work showing haemoglobin levels, and a summary of symptoms and previous treatments — for a preliminary assessment by a specialist team. This remote review helps determine the most appropriate treatment approach before committing to travel.
